RSS

licence agreement

A two-year strategic research collaboration and licence agreement has been formed between Karolinska Institute spin out, Pelago Bioscience, and Vertex Pharmaceuticals that will focus on the CETSA method. Read more

News

Biotechnology company, Leukocare, and pharma company, Boehringer Ingelheim, have entered into a licence agreement in the field of veterinary diagnostics. Read more

News

Karolinska Institute spin out company, Pelago Bioscience, has entered into a strategic research collaboration and licence agreement with AstraZeneca for the further advancement of the CETSA method and its use in pre-clinical discovery Read more

News

A licence and distribution agreement has been formed between Grünenthal and Mundipharma, which will see Mundipharma market and distribute Tramal (tramadol) in China from the beginning of May. Read more

News

An exclusive licence agreement has been announced for the importation, packaging and commercialisation of Opicapone — a new treatment for Parkinson’s disease — in China (excluding Hong Kong, Macao and Taiwan). Read more

News

Licence terms for the exclusive development and commercialisation rights to certain macrocyclic inhibitors of peptide bond isomerases (cyprolides) have been agreed upon by Cypralis and Gilead Sciences. Read more

News

Horizon Discovery Group has extended its pre-existing non-exclusive, worldwide licence agreement with ERS Genomics to expand its coverage for the use of CRISPR gene editing technology. Read more

News

Italian pharmaceutical company, NTC, has granted licence and distribution rights of a portfolio of ophthalmic products to Mundipharma — a pharmaceutical company with a presence in ophthalmology. Read more

News

Supplier of research reagents, Cambridge Research Biochemicals (CRB), has signed a licence agreement with Edinburgh Innovations, which is the Innovations Management Service for The University of Edinburgh. Read more

Technology